 |
Mx-dnG1 or Rexin-G retroviral vector |
|---|---|
| Trade Name | Rexin-G |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2003-08-15 00:00:00 |
| Sponsor | Epeius Biotechnologies Corporation;345 Pioneer Drive, 1803W;Glendale, California, 91203 |
